Optical Preclinical Imaging Market Expected to Reach $859.70 Million by 2030

Optical preclinical imaging market was valued at $516.10 million in 2020, and is projected to reach $859.70 million by 2030, growing at a CAGR of 5.2% from 2021 to 2030. Optical imaging device serves as a standard tool in preclinical drug discovery and development. This modality offers a virtual window inside the animals, thus facilitating the tracking of biological activities at the molecular level. This method is simple to use, offers fast throughput, is reasonably priced with outstanding sensitivity, and does not emit radiations.

𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 :
Berthold Technologies GmbH & Co.KG, Endress+Hauser (Analytik Jena US LLC), Fujifilm Corporation (Fujifilm VisualSonics Inc.), LI-COR Biosciences, Inc., Miltenyi Biotec B.V. & CO. KG, PerkinElmer, Inc., Rigaku Corporation (MILabs B.V.), TriFoil Imaging

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/10711

Noninvasive in vivo imaging methods have elevated the use of animal models in preclinical drug discovery and development to a new level, allowing rapid and efficient drug effectiveness screening. During the preclinical stage of drug discovery and development research, in vitro and in vivo testing are performed to ensure that the drug candidate is safe to test in humans prior to the beginning of clinical trials. Animal models are used in preclinical research to help in the exploration of human diseases and the development of novel treatments. The biological relevance of an animal model is crucial for clinical outcome prediction.

The major objective of preclinical imaging is to enhance the probability of clinical success while shortening the time and expense of drug R&D. Nuclear medicine techniques (primarily positron emission tomography [PET] and single photon emission computed tomography [SPECT]), optical imaging (OI), computed tomography (CT), magnetic resonance imaging (MRI), magnetic resonance spectroscopy imaging (MRSI), and ultrasound are the most appropriate modalities for small animal in vivo imaging applications. Each modality has its own set of advantages and disadvantages.

Noninvasive, whole-body in vivo optical imaging enables the monitoring and assessment of diseases, drug biodistribution, and molecular events in small animals by labelling them with light emitting reporters. Tumor cells, stem cells, immunological cells, gene therapy, viruses, or bacteria, for example, can be genetically tagged with a fluorescent protein. The biodistribution of drug delivery nanoparticles and biologicals (for example, antibodies) can be tracked by marking the moiety with a fluorescent dye. In vivo optical imaging can assist researchers to monitor biodistribution, cellular or genetic activity, and utilize the data to track medications, gene expression, disease transmission, or the impacts of a novel drug candidate by monitoring and analyzing light output.

𝐁𝐮𝐲 𝐍𝐨𝐰 https://www.alliedmarketresearch.com/checkout-final/1c8b88cd6c1915a4044afbe1f93f07b3

By modality, the market is fragmented into bioluminescence & fluorescence imaging systems, standalone fluorescence imaging systems, and optical + X-ray & optical + CT. The bioluminescence & fluorescence imaging systems segment generated maximum revenue in 2020, accounting $245.40 million. The optical + X-ray & optical + CT segment is expected to witness highest CAGR of 5.7% during the forecast period.

Depending on end user, the market is differentiated into pharma & biotech companies, academic & government research institutes and contract research organizations. The contract research organizations segment dominated the market in 2020 with $245.30 million and is expected to witness highest CAGR of 5.8% during the forecast period.

North America accounted for a majority of the global optical preclinical imaging market share in 2020, and is anticipated to remain dominant during the forecast period. This is attributed to increase in adoption of advanced technologies, presence of key players, and rise healthcare expenditure in the region. However, Asia-Pacific is anticipated to witness notable growth, owing to rise in R&D activities in preclinical studies, and increase in investments in the healthcare sector in the region.

𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 https://www.alliedmarketresearch.com/purchase-enquiry/10711

𝐊𝐄𝐘 𝐅𝐈𝐍𝐃𝐈𝐍𝐆𝐒 𝐎𝐅 𝐓𝐇𝐄 𝐒𝐓𝐔𝐃𝐘

By modality, bioluminescence & fluorescence imaging systems was the highest contributor to the market in 2020.

By end user, contract research organizations segment exhibited the highest growth in 2020, and is expected to continue this trend during the forecast period.

By region, North America garnered the largest revenue share in 2020, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

𝐎𝐮𝐫 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧 𝐏𝐫𝐨𝐯𝐢𝐝𝐞𝐬 𝐘𝐨𝐮 𝐀𝐧𝐬𝐰𝐞𝐫 𝐭𝐨 𝐁𝐞𝐥𝐨𝐰 𝐌𝐞𝐧𝐭𝐢𝐨𝐧𝐞𝐝 𝐐𝐮𝐞𝐬𝐭𝐢𝐨𝐧:

• Which are the driving factors responsible for the growth of market?
• Which are the roadblock factors of this market?
• What are the new opportunities, by which market will grow in coming years?
• What are the trends of this market?
• Which are main factors responsible for new product launch?
• How big is the global & regional market in terms of revenue, sales and production?
• How far will the market grow in forecast period in terms of revenue, sales and production?
• Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
• How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
• Which region has more opportunities?

Contact:

David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.